1035 related articles for article (PubMed ID: 29077002)
21. Mechanistic target of rapamycin (mTOR) regulates trophoblast folate uptake by modulating the cell surface expression of FR-α and the RFC.
Rosario FJ; Powell TL; Jansson T
Sci Rep; 2016 Aug; 6():31705. PubMed ID: 27562465
[TBL] [Abstract][Full Text] [Related]
22. Targeting mTORC1/2 with OSI-027 inhibits proliferation and migration of keloid keratinocytes.
Chen J; Liu K; Liu Y; Wang X; Zhang Z
Exp Dermatol; 2019 Mar; 28(3):270-275. PubMed ID: 30650200
[TBL] [Abstract][Full Text] [Related]
23. Control of B lymphocyte development and functions by the mTOR signaling pathways.
Iwata TN; Ramírez-Komo JA; Park H; Iritani BM
Cytokine Growth Factor Rev; 2017 Jun; 35():47-62. PubMed ID: 28583723
[TBL] [Abstract][Full Text] [Related]
24. ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer.
Harwood FC; Klein Geltink RI; O'Hara BP; Cardone M; Janke L; Finkelstein D; Entin I; Paul L; Houghton PJ; Grosveld GC
Sci Adv; 2018 Sep; 4(9):eaar3938. PubMed ID: 30258985
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
Brown AL; Fluitt MB; Ecelbarger CM
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113
[TBL] [Abstract][Full Text] [Related]
26. Dynamic modelling of the PI3K/MTOR signalling network uncovers biphasic dependence of mTORC1 activity on the mTORC2 subunit SIN1.
Ghomlaghi M; Yang G; Shin SY; James DE; Nguyen LK
PLoS Comput Biol; 2021 Sep; 17(9):e1008513. PubMed ID: 34529665
[TBL] [Abstract][Full Text] [Related]
27. Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission.
McCabe MP; Cullen ER; Barrows CM; Shore AN; Tooke KI; Laprade KA; Stafford JM; Weston MC
Elife; 2020 Mar; 9():. PubMed ID: 32125271
[TBL] [Abstract][Full Text] [Related]
28. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling.
Yu Y; Yoon SO; Poulogiannis G; Yang Q; Ma XM; Villén J; Kubica N; Hoffman GR; Cantley LC; Gygi SP; Blenis J
Science; 2011 Jun; 332(6035):1322-6. PubMed ID: 21659605
[TBL] [Abstract][Full Text] [Related]
29. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
30. The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2.
Warren KJ; Fang X; Gowda NM; Thompson JJ; Heller NM
J Biol Chem; 2016 Nov; 291(48):24922-24930. PubMed ID: 27742835
[TBL] [Abstract][Full Text] [Related]
31. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
[TBL] [Abstract][Full Text] [Related]
32. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling.
Hsu PP; Kang SA; Rameseder J; Zhang Y; Ottina KA; Lim D; Peterson TR; Choi Y; Gray NS; Yaffe MB; Marto JA; Sabatini DM
Science; 2011 Jun; 332(6035):1317-22. PubMed ID: 21659604
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic Target of Rapamycin Complex 1 Promotes the Expression of Genes Encoding Electron Transport Chain Proteins and Stimulates Oxidative Phosphorylation in Primary Human Trophoblast Cells by Regulating Mitochondrial Biogenesis.
Rosario FJ; Gupta MB; Myatt L; Powell TL; Glenn JP; Cox L; Jansson T
Sci Rep; 2019 Jan; 9(1):246. PubMed ID: 30670706
[TBL] [Abstract][Full Text] [Related]
34. The 3.2-Å resolution structure of human mTORC2.
Scaiola A; Mangia F; Imseng S; Boehringer D; Berneiser K; Shimobayashi M; Stuttfeld E; Hall MN; Ban N; Maier T
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33158864
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.
Talos DM; Jacobs LM; Gourmaud S; Coto CA; Sun H; Lim KC; Lucas TH; Davis KA; Martinez-Lage M; Jensen FE
Ann Neurol; 2018 Feb; 83(2):311-327. PubMed ID: 29331082
[TBL] [Abstract][Full Text] [Related]
36. mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme.
Ramaiah MJ; Kumar KR
Mol Biol Rep; 2021 May; 48(5):4813-4835. PubMed ID: 34132942
[TBL] [Abstract][Full Text] [Related]
37. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
Zou Z; Chen J; Yang J; Bai X
Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
[TBL] [Abstract][Full Text] [Related]
38. Dynamic modeling of signal transduction by mTOR complexes in cancer.
Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
[TBL] [Abstract][Full Text] [Related]
39. Growing knowledge of the mTOR signaling network.
Huang K; Fingar DC
Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279
[TBL] [Abstract][Full Text] [Related]
40. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]